170 related articles for article (PubMed ID: 30106248)
21. Augmenting one-session treatment of children's specific phobias with attention training to positive stimuli.
Waters AM; Farrell LJ; Zimmer-Gembeck MJ; Milliner E; Tiralongo E; Donovan CL; McConnell H; Bradley BP; Mogg K; Ollendick TH
Behav Res Ther; 2014 Nov; 62():107-19. PubMed ID: 25156398
[TBL] [Abstract][Full Text] [Related]
22. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
23. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
24. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
[TBL] [Abstract][Full Text] [Related]
25. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
[TBL] [Abstract][Full Text] [Related]
26. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
[TBL] [Abstract][Full Text] [Related]
27. D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence.
Santa Ana EJ; Prisciandaro JJ; Saladin ME; McRae-Clark AL; Shaftman SR; Nietert PJ; Brady KT
Am J Addict; 2015 Apr; 24(3):217-224. PubMed ID: 25808169
[TBL] [Abstract][Full Text] [Related]
28. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
[TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
Leyfer O; Carpenter A; Pincus D
Child Psychiatry Hum Dev; 2019 Apr; 50(2):268-277. PubMed ID: 30078111
[TBL] [Abstract][Full Text] [Related]
30. Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
Smits JAJ; Zvolensky MJ; Otto MW; Piper ME; Baird SO; Kauffman BY; Lee-Furman E; Alavi N; Dutcher CD; Papini S; Rosenfield B; Rosenfield D
Drug Alcohol Depend; 2020 Mar; 208():107877. PubMed ID: 32004998
[TBL] [Abstract][Full Text] [Related]
31. Specific phobias in youth: a randomized controlled trial comparing one-session treatment to a parent-augmented one-session treatment.
Ollendick TH; Halldorsdottir T; Fraire MG; Austin KE; Noguchi RJ; Lewis KM; Jarrett MA; Cunningham NR; Canavera K; Allen KB; Whitmore MJ
Behav Ther; 2015 Mar; 46(2):141-55. PubMed ID: 25645164
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
Reinecke A; Nickless A; Browning M; Harmer CJ
Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
[TBL] [Abstract][Full Text] [Related]
33. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals.
Price KL; Baker NL; McRae-Clark AL; Saladin ME; Desantis SM; Santa Ana EJ; Brady KT
Psychopharmacology (Berl); 2013 Apr; 226(4):739-46. PubMed ID: 22234379
[TBL] [Abstract][Full Text] [Related]
34. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.
Ori R; Amos T; Bergman H; Soares-Weiser K; Ipser JC; Stein DJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD007803. PubMed ID: 25957940
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
37. One-session treatment compared with multisession CBT in children aged 7-16 years with specific phobias: the ASPECT non-inferiority RCT.
Wright B; Tindall L; Scott AJ; Lee E; Biggs K; Cooper C; Bee P; Wang HI; Gega L; Hayward E; Solaiman K; Teare MD; Davis T; Lovell K; Wilson J; McMillan D; Barr A; Edwards H; Lomas J; Turtle C; Parrott S; Teige C; Chater T; Hargate R; Ali S; Parkinson S; Gilbody S; Marshall D
Health Technol Assess; 2022 Oct; 26(42):1-174. PubMed ID: 36318050
[TBL] [Abstract][Full Text] [Related]
38. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
39. One session treatment for specific phobias in children: Comorbid anxiety disorders and treatment outcome.
Ryan SM; Strege MV; Oar EL; Ollendick TH
J Behav Ther Exp Psychiatry; 2017 Mar; 54():128-134. PubMed ID: 27474792
[TBL] [Abstract][Full Text] [Related]
40. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]